Found: 25
Select item for more details and to access through your institution.
Are products with an orphan designation for oncology indications different from products for other rare indications? A retrospective analysis of European orphan designations granted between 2002-2012.
- Published in:
- 2017
- By:
- Publication type:
- journal article
What Does Society Value About Cancer Medicines? A Discrete Choice Experiment in the Belgian Population.
- Published in:
- Applied Health Economics & Health Policy, 2019, v. 17, n. 6, p. 895, doi. 10.1007/s40258-019-00504-4
- By:
- Publication type:
- Article
Clinical, Economic and Policy Implications of Drug Shortages in the European Union.
- Published in:
- Applied Health Economics & Health Policy, 2017, v. 15, n. 4, p. 441, doi. 10.1007/s40258-016-0264-z
- By:
- Publication type:
- Article
Paving a regulatory pathway for phage therapy. Europe should muster the resources to financially, technically and legally support the introduction of phage therapy.
- Published in:
- EMBO Reports, 2013, v. 14, n. 11, p. 951, doi. 10.1038/embor.2013.163
- By:
- Publication type:
- Article
Meropenem-valproic acid interaction in patients with cefepime-associated status epilepticus.
- Published in:
- American Journal of Health-System Pharmacy, 2007, v. 64, n. 1, p. 54, doi. 10.2146/ajhp050512
- By:
- Publication type:
- Article
Overall performance of a drug-drug interaction clinical decision support system: quantitative evaluation and end-user survey.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Presence of thiamine pyrophosphate in mammalian peroxisomes.
- Published in:
- BMC Biochemistry, 2007, v. 8, p. 10, doi. 10.1186/1471-2091-8-10
- By:
- Publication type:
- Article
Insights into European Drug Shortages: A Survey of Hospital Pharmacists.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0119322
- By:
- Publication type:
- Article
Call for a Dedicated European Legal Framework for Bacteriophage Therapy.
- Published in:
- Archivum Immunologiae & Therapiae Experimentalis, 2014, v. 62, n. 2, p. 117, doi. 10.1007/s00005-014-0269-y
- By:
- Publication type:
- Article
Optimizing the European Regulatory Framework for Sustainable Bacteriophage Therapy in Human Medicine.
- Published in:
- Archivum Immunologiae & Therapiae Experimentalis, 2012, v. 60, n. 3, p. 161, doi. 10.1007/s00005-012-0175-0
- By:
- Publication type:
- Article
α-Oxidation in Intact and Permeabilized Rat Hepatocytes.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 804, n. 1, p. 682, doi. 10.1111/j.1749-6632.1996.tb18666.x
- By:
- Publication type:
- Article
Osteoporosis after combined use of a neuroleptic and antidepressants.
- Published in:
- Pharmacy World & Science, 2008, v. 30, n. 5, p. 613, doi. 10.1007/s11096-008-9231-6
- By:
- Publication type:
- Article
Intussusception of the Vermiform Appendix.
- Published in:
- Journal of Pediatric Gastroenterology & Nutrition, 1986, v. 5, n. 1, p. 159
- By:
- Publication type:
- Article
The Impact of Customized Screening Intervals on the Burden of Drug-Drug Interaction Alerts: An Interrupted Time Series Analysis.
- Published in:
- Journal of Medical Systems, 2024, v. 48, n. 1, p. 1, doi. 10.1007/s10916-024-02113-8
- By:
- Publication type:
- Article
Sponsorship in non-commercial clinical trials: definitions, challenges and the role of Good Clinical Practices guidelines.
- Published in:
- BMC International Health & Human Rights, 2015, v. 15, p. 1, doi. 10.1186/s12914-015-0073-8
- By:
- Publication type:
- Article
Drug shortages in European countries: a trade-off between market attractiveness and cost containment?
- Published in:
- BMC Health Services Research, 2014, v. 14, n. 1, p. 438, doi. 10.1186/1472-6963-14-438
- By:
- Publication type:
- Article
Drug shortages in European countries: a trade-off between market attractiveness and cost containment?
- Published in:
- 2014
- By:
- Publication type:
- journal article
High-risk medication in community care: a scoping review.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 5, p. 623, doi. 10.1007/s00228-020-02838-8
- By:
- Publication type:
- Article
Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology Drugs.
- Published in:
- Frontiers in Pharmacology, 2016, p. 1, doi. 10.3389/fphar.2016.00144
- By:
- Publication type:
- Article
Time Investment in Drug Supply Problems by Flemish Community Pharmacies.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00568
- By:
- Publication type:
- Article
Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the Future.
- Published in:
- Frontiers in Pharmacology, 2017, v. 8, p. 1, doi. 10.3389/fphar.2017.00171
- By:
- Publication type:
- Article
Market access of cancer drugs in European countries: improving resource allocation.
- Published in:
- Targeted Oncology, 2014, v. 9, n. 2, p. 95, doi. 10.1007/s11523-013-0301-x
- By:
- Publication type:
- Article
The necessity for a European definition of drug shortages.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Development and implementation of "Check of Medication Appropriateness" (CMA): advanced pharmacotherapy-related clinical rules to support medication surveillance.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: An exploratory study.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0174556
- By:
- Publication type:
- Article